New sedative aims to keep ICU patients comfortable and safe

NCT ID NCT06222294

First seen Jan 10, 2026 · Last updated May 11, 2026 · Updated 16 times

Summary

This study tested a new sedative called remimazolam tosilate in 214 ICU patients who were on breathing machines. The goal was to see if it could safely keep patients at the right level of calm without needing extra rescue medication. Results will help doctors choose better sedation options for critically ill patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEDATION IN THE ICU are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510080, China

Conditions

Explore the condition pages connected to this study.